
FDA Grants Breakthrough Device Designation to OraLiva’s Cytology Test for Suspicious Oral Lesions
DURHAM, N.C., October 30, 2026 – OraLiva, Inc., an early cancer detection company developing AI-enabled cytology diagnostics, today announced that
Delta Dental of Michigan, Delta Dental of North Carolina and OraLiva Inc. Announce Multi-State Launch of AI-Powered Oral Cancer Test
Read More
Stay informed with the latest developments from OraLiva

DURHAM, N.C., October 30, 2026 – OraLiva, Inc., an early cancer detection company developing AI-enabled cytology diagnostics, today announced that

DURHAM, NC, October 12, 2026: OraLiva, a mission-driven diagnostics company dedicated to catching cancer earlier, today announced that it has

Oral cancer is one of the few cancers dentists see coming and still, too often, catch too late. Most cases

OraLiva is pleased to announce a collaboration with Rovers Medical Devices, a global leader in medical sampling devices, to support

New collaboration covers non-invasive cytology and AI risk-stratification to dentists across Michigan, Ohio, Indiana, and North Carolina Durham, NC —
NEW YORK, Oct. 6, 2025 — OraLiva, Inc., an AI precision diagnostics company, today announced the close of a $2.0